These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17552958)

  • 1. The reliability of the frequency-volume chart in assessing lower urinary tract symptoms.
    Yap TL; Cromwell DA; Brown C; Emberton M; van der Meulen J
    BJU Int; 2007 Jul; 100(1):111-5. PubMed ID: 17552958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of self-management of lower urinary tract symptoms on frequency-volume chart measures.
    Yap TL; Brown C; Cromwell DA; van der Meulen J; Emberton M
    BJU Int; 2009 Oct; 104(8):1104-8. PubMed ID: 19485993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between objective frequency-volume chart data and the I-PSS in men with lower urinary tract symptoms.
    Yap TL; Cromwell DA; Brown C; van der Meulen J; Emberton M
    Eur Urol; 2007 Sep; 52(3):811-8. PubMed ID: 17276583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
    Kaplan SA; Roehrborn CG; Chancellor M; Carlsson M; Bavendam T; Guan Z
    BJU Int; 2008 Nov; 102(9):1133-9. PubMed ID: 18510659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of International Prostate Symptom Score voiding-to-storage subscore ratio in male lower urinary tract symptoms.
    Liao CH; Chung SD; Kuo HC
    Int J Clin Pract; 2011 May; 65(5):552-8. PubMed ID: 21489080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of voiding position on uroflowmetric parameters and post-void residual urine volume in patients with benign prostatic hyperplasia.
    Unsal A; Cimentepe E
    Scand J Urol Nephrol; 2004; 38(3):240-2. PubMed ID: 15204379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and predictive value of voiding diary data versus prostate volume, maximal free urinary flow rate, and Abrams-Griffiths number in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    van Venrooij GE; van Melick HH; Eckhardt MD; Boon TA
    Urology; 2008 Mar; 71(3):469-74. PubMed ID: 18342189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial comment on: the relationship between objective frequency-volume chart data and the I-PSS in men with lower urinary tract symptoms.
    De Nunzio C
    Eur Urol; 2007 Sep; 52(3):818. PubMed ID: 17276582
    [No Abstract]   [Full Text] [Related]  

  • 9. Does sildenafil affect uroflowmetry values in men with lower urinary tract symptoms suggestive of benign prostatic enlargement?
    Güler C; Tüzel E; Doğantekin E; Kiziltepe G
    Urol Int; 2008; 80(2):181-5. PubMed ID: 18362490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The optimal duration of frequency-volume charts related to compliance and reliability.
    van Haarst EP; Bosch JL
    Neurourol Urodyn; 2014 Mar; 33(3):296-301. PubMed ID: 24166989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nocturia in patients with lower urinary tract symptoms: association with diurnal voiding patterns.
    Ku JH; Lim DJ; Byun SS; Paick JS; Oh SJ
    BJU Int; 2004 May; 93(7):1005-8. PubMed ID: 15142152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
    Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
    BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha-blocker monotherapy in the treatment of nocturia in men with lower urinary tract symptoms: a prospective study of response prediction.
    Paick JS; Ku JH; Shin JW; Yang JH; Kim SW
    BJU Int; 2006 May; 97(5):1017-23. PubMed ID: 16643483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the elements of overactive bladder: questions raised by the EPIC study.
    Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
    BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgens and bladder outlet obstruction: a correlation with pressure-flow variables in a preliminary study.
    Koritsiadis G; Stravodimos K; Mitropoulos D; Doumanis G; Fokitis I; Koritsiadis S; Constantinides C
    BJU Int; 2008 Jun; 101(12):1542-6. PubMed ID: 18294304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Core Lower Urinary Tract Symptom score (CLSS) questionnaire: a reliable tool in the overall assessment of lower urinary tract symptoms.
    Homma Y; Yoshida M; Yamanishi T; Gotoh M
    Int J Urol; 2008 Sep; 15(9):816-20. PubMed ID: 18657204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between erectile dysfunction and lower urinary tract symptoms due to benign prostatic hyperplasia in Nigerian men.
    Ikuerowo SO; Akindiji YO; Akinoso OA; Akinlusi FM; Esho JO
    Urol Int; 2008; 80(3):296-9. PubMed ID: 18480635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of autonomic nervous system activity in men with lower urinary tract symptoms (LUTS): analysis of heart rate variability in men with LUTS.
    Choi JB; Lee JG; Kim YS
    Urology; 2010 Jan; 75(1):138-42. PubMed ID: 19854482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency volume charts in the assessment and evaluation of treatment: how should we use them?
    Bryan NP; Chapple CR
    Eur Urol; 2004 Nov; 46(5):636-40. PubMed ID: 15474275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 3-day bladder diary is a feasible, reliable and valid tool to evaluate the lower urinary tract symptoms in women.
    Jimenez-Cidre MA; Lopez-Fando L; Esteban-Fuertes M; Prieto-Chaparro L; Llorens-Martinez FJ; Salinas-Casado J; Castro-Diaz D; Müller-Arteaga C; Adot-Zurbano JM; Rodriguez-Escobar F; Gutierrez C; Arlandis-Guzman S; Bonillo-Garcia MA; Madurga-Patuel B; Leva-Vallejo M; Franco de Castro A; Peri-Cusi L; Conejero-Sugrañes J; Jimenez-Calvo J; Rebollo P; Mora A
    Neurourol Urodyn; 2015 Feb; 34(2):128-32. PubMed ID: 24264859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.